National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients (CARMEN)
National Evaluation of the Adherence to Recommendations of VTE Treatment in Cancer Patients
Sponsor: Centre Hospitalier Universitaire, Amiens
This observational or N/A phase trial investigates Neoplasms and Venous Thromboembolism and is currently completed. Centre Hospitalier Universitaire, Amiens leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
May 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centre Hospitalier Universitaire, Amiens
- Floralis
- Groupe Francophone Thrombose et Cancer (GFTC)
- University Hospital, Grenoble
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Annecy, France , Argenteuil, France , Auch, France , Beauvais, France , Bordeaux, France , Brest, France , Caen, France , Carcassonne, France , Castelnau-le-Lez, France , Chambray-lès-Tours, France and 24 more locations